The experimental use of novobiocin (cathomycin) and other antibiotics in the treatment of experimentally produced purulent arthritis.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000904:Antibiotics, Antitubercular; D001169:Arthritis, Experimental; D001170:Arthritis, Infectious; D009675:Novobiocin
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D009675:Novobiocin
ANTIBIOTICS/effects; ARTHRITIS/experimental